title: Lysosomal membrane permeabilization induces cell death in human mast cells.
abstract: Mast cells (MC) have pathogenic roles in numerous disorders, and strategies that stabilize MC or induce MC apoptosis are therefore emerging as possible therapeutic regimens. A typical feature of MC is their high content of secretory lysosomes (granules), containing numerous components such as biogenic amines, cytokines, serglycin proteoglycan and proteases. Damage to the secretory lysosomes will thus lead to leakage of these compounds, including the proteases, into the cytosol, and this could potentially trigger apoptosis. Here, we evaluated whether MC are sensitive to cell death induced by secretory lysosome destabilization, induced by the lysosomotropic agent Leu-Leu-OMe (LLME). Human MC were sensitive to LLME-induced cell death. In contrast, fibroblasts and HEK-293 cells were largely resistant. As judged by Annexin V/propidium iodide staining, LLME caused apoptotic cell death, and this was supported by induction of caspase-3-like activity, detection of activated caspase-3 by immunoblot analysis and reduced cell death in the presence of a caspase inhibitor. In support of a role for serglycin in regulating LLME-induced cell death, the survival rate of various cell types correlated negatively with the level of serglycin expression. In summary, this study introduces the concept of using lysosomotropic agents to induce cell death of human MC.
authors.affiliation: Department of Anatomy, Physiology and Biochemistry, BMC, Swedish University of Agricultural Sciences, Uppsala, Sweden.
authors.forename: F R
authors.initials: FR
authors.lastname: Melo
authors.forename: A
authors.initials: A
authors.lastname: Lundequist
authors.forename: G
authors.initials: G
authors.lastname: Calounova
authors.forename: S
authors.initials: S
authors.lastname: Wernersson
authors.forename: G
authors.initials: G
authors.lastname: Pejler
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D053148:Caspase 3 / Q000096:biosynthesis / Q000378:metabolism; D002470:Cell Survival; D002478:Cells, Cultured; D004151:Dipeptides / Q000494:pharmacology*; D004789:Enzyme Activation; D005434:Flow Cytometry; D057809:HEK293 Cells; D006801:Humans; D007425:Intracellular Membranes / Q000187:drug effects / Q000378:metabolism*; D008247:Lysosomes / Q000187:drug effects / Q000378:metabolism*; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D010539:Permeability; D016133:Polymerase Chain Reaction; D011509:Proteoglycans / Q000096:biosynthesis / Q000378:metabolism; D033921:Vesicular Transport Proteins / Q000096:biosynthesis / Q000378:metabolism
chemical_list: D004151:Dipeptides; D011509:Proteoglycans; D033921:Vesicular Transport Proteins; C075430:serglycin; C045139:leucyl-leucine-methyl ester; D053148:Caspase 3